Halberd Corporation Asset Turnover Ratio (HALB), as of third quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Halberd Corporation  (HALB)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Halberd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Halberd Corporation asset turnover ratio, the ability of Halberd Corporation's assets to generate revenue in the third quarter 2022, increased sequentially to 0.11 in the third quarter (Apr 30 2022), HALB's balance sheet remain strong.

Within sector Halberd Corporation achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2022 compared to previous quarter at no. .

Asset Turnover Ratio Definition



HALB Asset Turnover Ratio (Apr 30 2022)
III. Quarter
(Apr 30 2021)
III. Quarter



Y / Y Asset Change - - - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.11 0.07 - - -
HALB's Total Ranking # # # # #
Seq. Asset Change -70.95 % - - - -
Seq. Revenue Change 10.64 % - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Apr 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Apr 30 2022 Assets at quarter ending Apr 30 2022
United Therapeutics Corporation  0.35 $ 1,768.300  Millions$ 5,105.675  Millions
Medtronic Plc  0.34 $ 31,686.000  Millions$ 91,905.500  Millions
Illumina Inc   0.34 $ 4,656.000  Millions$ 13,557.250  Millions
Veru Inc   0.34 $ 60.466  Millions$ 177.298  Millions
Sotera Health Company  0.34 $ 956.084  Millions$ 2,804.785  Millions
Lipocine Inc   0.34 $ 15.958  Millions$ 46.914  Millions
Cytek Biosciences Inc   0.34 $ 138.742  Millions$ 408.446  Millions
Athenex Inc   0.34 $ 108.880  Millions$ 324.790  Millions
Ionis Pharmaceuticals Inc   0.33 $ 840.768  Millions$ 2,510.686  Millions
1life Healthcare Inc   0.33 $ 756.065  Millions$ 2,265.067  Millions
Sonida Senior Living Inc   0.33 $ 231.554  Millions$ 696.247  Millions
Crispr Therapeutics Ag  0.33 $ 915.364  Millions$ 2,769.824  Millions
Neuropace Inc   0.33 $ 45.340  Millions$ 137.693  Millions
Orthopediatrics Corp  0.33 $ 100.004  Millions$ 304.129  Millions
Endo International Plc  0.33 $ 2,927.546  Millions$ 8,916.859  Millions
Zimmer Biomet Holdings Inc   0.33 $ 7,652.000  Millions$ 23,326.425  Millions
Repligen Corp  0.33 $ 734.097  Millions$ 2,249.885  Millions
Clarus Therapeutics Holdings Inc.  0.32 $ 15.638  Millions$ 48.136  Millions
Teva Pharmaceutical Industries Limited  0.32 $ 15,557.000  Millions$ 47,942.750  Millions
Kyntra Bio Inc   0.32 $ 257.707  Millions$ 794.722  Millions
Arcus Biosciences Inc   0.32 $ 391.426  Millions$ 1,218.347  Millions
Emmaus Life Sciences Inc   0.32 $ 18.509  Millions$ 57.891  Millions
Viatris Inc   0.32 $ 17,647.700  Millions$ 55,591.050  Millions
Biomarin Pharmaceutical Inc  0.31 $ 1,879.604  Millions$ 5,985.501  Millions
The Cooper Companies Inc   0.31 $ 3,139.500  Millions$ 10,150.250  Millions
Precipio inc   0.31 $ 9.472  Millions$ 30.889  Millions
Akoya Biosciences Inc   0.31 $ 59.599  Millions$ 194.947  Millions
Prestige Consumer Healthcare Inc   0.30 $ 1,086.812  Millions$ 3,583.722  Millions
Phenomex Inc   0.30 $ 86.966  Millions$ 287.495  Millions
Precigen Inc   0.30 $ 111.383  Millions$ 368.724  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.